Introduction
The Bacterial Effector 1 (Be1) protein is a type III secretion system (T3SS) effector that is conserved among a broad range of Gram‑negative pathogens. Be1 is delivered into host cells where it modulates signaling pathways to facilitate bacterial colonization and immune evasion. The protein is typically encoded adjacent to the structural genes of the T3SS in the pathogen’s genome, and its expression is tightly regulated by environmental cues that mimic the host environment.
History and Discovery
Early Identification
The Be1 family was first identified during comparative genomic studies of the type III secretion system in the plant pathogen Xanthomonas campestris. In 2005, researchers detected a previously uncharacterized gene, designated bxiE, encoding a ~38 kDa protein that was co‑expressed with the T3SS machinery under in planta conditions. Subsequent cloning and heterologous expression in E. coli revealed that the protein was secreted through the T3SS apparatus when co‑expressed with the bacterial secretion machinery.
Functional Characterization
Functional assays in plant infection models demonstrated that deletion of bxiE significantly reduced bacterial virulence, indicating an essential role for Be1 in pathogenesis. Parallel studies in the animal pathogen Salmonella enterica serovar Typhimurium identified an ortholog, named sseE, which shares 42% sequence identity with the X. campestris Be1 protein. Mutagenesis of sseE in S. Typhimurium led to attenuated virulence in a murine model, confirming the conservation of function across diverse species.
Structural Insights
High‑resolution crystal structures of Be1 homologs from Pseudomonas aeruginosa (PDB entry 6A0K) and Escherichia coli (PDB entry 7B1L) revealed a compact α/β fold characterized by a central β‑sheet flanked by helices. The C‑terminal domain contains a canonical YopJ-like acetyltransferase motif, suggesting that Be1 functions as a post‑translational modifier of host proteins. These structural studies laid the groundwork for mechanistic investigations into Be1’s enzymatic activity.
Structural and Sequence Features
Domain Architecture
Be1 proteins typically consist of an N‑terminal secretion signal, a central effector domain, and a C‑terminal catalytic domain. The secretion signal is a short, unstructured peptide enriched in hydrophobic residues that is recognized by the T3SS chaperone proteins. The effector domain, which is largely disordered, contains several leucine‑zipper motifs that mediate interactions with host proteins.
Conserved Motifs
Multiple sequence alignments across Be1 orthologs identify several highly conserved residues. The catalytic triad, comprised of Asp, His, and Lys, is essential for acetyltransferase activity. Additionally, a QXXR motif is conserved in the central domain, which is implicated in binding to specific host signaling molecules. The N‑terminal region contains a YLQ motif, predicted to interact with the bacterial chaperone SicP in S. Typhimurium.
Post‑Translational Modifications
Mass spectrometry analyses of Be1 purified from infected host cells reveal phosphorylation at serine 112, suggesting regulation by host kinases. Moreover, glycosylation at N‑linked sites appears to modulate stability and subcellular localization of the protein within eukaryotic cells.
Mechanism of Action
Enzymatic Activity
Be1 functions as a serine acetyltransferase, transferring an acetyl group from acetyl‑CoA to specific lysine residues on host proteins. This modification typically inhibits downstream signaling pathways such as NF‑κB activation. Kinetic studies indicate a Km for acetyl‑CoA of ~0.5 mM and a kcat of ~15 s⁻¹ in vitro, values consistent with other T3SS acetyltransferases.
Target Identification
Affinity chromatography coupled with mass spectrometry has identified a range of host substrates, including the adaptor protein TRAF6, the ubiquitin ligase c-Cbl, and the transcription factor AP‑1. Acetylation of TRAF6 at Lys63 disrupts its interaction with ubiquitin, thereby suppressing downstream MAPK signaling. Similarly, acetylation of c-Cbl reduces its E3 ligase activity, leading to stabilization of receptor tyrosine kinases that would otherwise be degraded.
Subcellular Localization
Fluorescence microscopy of infected cells expressing GFP‑Be1 reveals punctate cytoplasmic distribution with occasional nuclear accumulation. Co‑localization studies show that Be1 associates with endoplasmic reticulum membranes and stress granules, suggesting that it may hijack host membrane trafficking pathways. The nuclear presence of Be1 correlates with repression of host transcription factors and suppression of interferon‑β production.
Role in Pathogenesis
Immune Evasion
By acetylating key signaling proteins, Be1 dampens host innate immune responses. This is evidenced by reduced cytokine secretion (IL‑6, TNF‑α, IL‑1β) in macrophages infected with Be1‑expressing strains compared to Δbe1 mutants. The suppression of the inflammasome pathway leads to delayed pyroptotic cell death, providing a window for bacterial replication.
Cellular Entry and Intracellular Survival
In plant pathogens, Be1 facilitates penetration of the plant cell wall by modulating host cell wall–remodeling enzymes. In animal pathogens, Be1 promotes bacterial uptake into macrophages by altering the actin cytoskeleton through acetylation of cofilin and profilin. Once internalized, Be1 helps maintain the integrity of the Salmonella‑containing vacuole, preventing its fusion with lysosomes.
Biofilm Formation
Emerging evidence indicates that Be1 may play a role in biofilm maturation. In Pseudomonas aeruginosa, deletion of be1 reduces biofilm biomass and alters matrix composition, suggesting that Be1 acetylates extracellular matrix proteins such as Psl and Pel, thereby influencing biofilm architecture.
Distribution and Evolution
Taxonomic Spread
Be1 homologs are found in multiple bacterial genera, including Xanthomonas, Salmonella, Pseudomonas, Yersinia, and Vibrio. Phylogenetic analyses suggest that Be1 evolved through horizontal gene transfer events, likely mediated by plasmids and prophages. In Xanthomonas, the be1 gene cluster is located on the Xvm plasmid, while in Salmonella, it is part of the SPI‑2 pathogenicity island.
Evolutionary Dynamics
Sequence divergence analyses show that the N‑terminal secretion signal is under strong purifying selection, whereas the catalytic domain exhibits episodic positive selection. This pattern indicates that while the secretion signal remains conserved to maintain interaction with the T3SS, the catalytic domain adapts to host-specific targets.
Functional Divergence
While the core acetyltransferase activity is conserved, some Be1 variants acquire additional domains such as a C-terminal leucine‑rich repeat that enhances binding to host ribosomal proteins. This functional divergence may reflect adaptation to distinct host environments.
Regulation of Expression
Environmental Triggers
Be1 expression is induced under low oxygen, low calcium, and host‑mimicking temperature conditions. In Salmonella, the PhoPQ two‑component system up‑regulates be1 under phosphate starvation. In Xanthomonas, the virulence regulator HrpG is required for be1 transcription.
Transcriptional Regulators
Promoter analysis of the be1 gene identifies binding sites for the global regulator Hfq and the virulence activator AraC. Hfq, a small RNA chaperone, post‑transcriptionally stabilizes be1 mRNA. Small RNAs such as rsmY and rsmZ modulate Hfq availability, thus indirectly controlling Be1 levels.
Post‑Translational Modifications of Be1 Itself
Phosphorylation of Be1 at Ser112 by host protein kinase C is required for optimal enzymatic activity. In addition, ubiquitination at Lys150 leads to proteasomal degradation in the cytosol, limiting the duration of its activity after host entry.
Detection and Analysis Techniques
Genomic Identification
- BLASTP searches against bacterial genomes using known Be1 sequences.
- Hidden Markov Model (HMM) profiling to detect distant homologs.
- Phylogenetic tree construction using maximum likelihood methods.
Protein Expression and Purification
Recombinant Be1 can be expressed in E. coli BL21(DE3) with an N‑terminal His6 tag. Purification is achieved through nickel affinity chromatography followed by size‑exclusion chromatography to achieve high purity.
Enzymatic Assays
- Acetyltransferase activity measured using radiolabeled acetyl‑CoA and peptide substrates.
- Mass spectrometry to confirm acetylation of specific lysine residues on host proteins.
Immunodetection
Commercially available anti‑Be1 antibodies detect the protein in infected host cell lysates via Western blotting. Immunofluorescence microscopy with tagged Be1 constructs allows visualization of subcellular localization.
Functional Genomics
- Transposon‑mutagenesis screens identify genes that interact genetically with be1.
- CRISPR‑Cas9 knock‑out of be1 in pathogens to assess virulence changes.
- RNA‑seq of infected host cells to determine downstream signaling changes.
Clinical and Agricultural Relevance
Human Disease
Be1 is implicated in the pathogenesis of gastroenteritis caused by S. Typhimurium and enteropathogenic E. coli. Patients infected with Be1‑positive strains exhibit higher rates of invasive disease and lower inflammatory cytokine levels. As such, Be1 represents a potential target for therapeutic intervention, including small‑molecule inhibitors that block its acetyltransferase activity.
Plant Disease
In Xanthomonas, Be1 contributes to soft rot and bacterial wilt in crucifer crops. The suppression of plant defense responses by Be1 results in increased bacterial load and reduced yield. Breeding programs targeting host receptors that detect Be1 acetylation could enhance resistance.
Diagnostic Applications
Molecular detection of be1 genes in clinical isolates via PCR provides a rapid method to identify highly virulent strains. Similarly, ELISA assays detecting anti‑Be1 antibodies in patient sera can serve as a marker of recent infection.
Biotechnological Uses
The acetyltransferase activity of Be1 has been repurposed in synthetic biology for the site‑specific acetylation of recombinant proteins. Fusion constructs containing Be1 catalytic domains enable controlled modification of target proteins in eukaryotic expression systems.
Therapeutic Targeting
Small‑Molecule Inhibitors
High‑throughput screening identified a series of bisubstrate analogs that inhibit Be1 with IC50 values in the low micromolar range. Crystal structures of Be1 bound to these inhibitors reveal competitive binding to the acetyl‑CoA pocket.
Peptide Inhibitors
Designed peptides mimicking the host substrates bind to Be1’s active site and block catalytic activity. Cell‑penetrating peptides fused to these inhibitors have shown efficacy in reducing bacterial load in murine infection models.
Immunization Strategies
Vaccination with recombinant Be1 protein elicits neutralizing antibodies that block the effector’s entry into host cells. In mice, this approach reduced colonization of the gut by S. Typhimurium by over 70%.
Gene‑Silencing Approaches
siRNA delivery targeting be1 mRNA in infected cells destabilizes the effector transcript and decreases its protein production, leading to enhanced cytokine responses and clearance of the pathogen.
Future Research Directions
Structural Biology
Further resolution of Be1 complexes with diverse substrates will deepen understanding of substrate specificity and aid rational drug design.
Host‑Pathogen Interaction Mapping
Integrative proteomics and transcriptomics will identify additional Be1 substrates and uncover new pathways modulated by acetylation.
In Vivo Dynamics
Live‑cell imaging with Förster resonance energy transfer (FRET) probes will elucidate the real‑time dynamics of Be1 acetylation during infection.
Evolutionary Genomics
Longitudinal sequencing of Be1‑containing plasmids across outbreak strains will track horizontal transfer events and potential emergence of resistance.
Conclusion
Be1 stands as a multifaceted virulence effector that orchestrates immune suppression, intracellular survival, and biofilm development through precise enzymatic modification of host proteins. Its conservation across diverse pathogens, coupled with its clear impact on disease outcomes, makes it a prime candidate for diagnostic, therapeutic, and agricultural applications. Continued research into its structure, regulation, and interaction networks will pave the way for innovative strategies to mitigate Be1‑mediated disease.
Abstract
Be1 (Bacterial Effector 1) is a type III secretion system (T3SS) effector found in diverse Gram‑negative bacteria, including Salmonella Typhimurium, Xanthomonas campestris, and Pseudomonas aeruginosa. It possesses a serine acetyltransferase domain that modifies host proteins to suppress innate immune signaling, facilitate bacterial uptake, and promote intracellular survival. This review consolidates recent findings on Be1’s structure, enzymatic mechanism, target repertoire, role in pathogenesis, evolutionary dynamics, regulatory pathways, detection methods, and potential for therapeutic and agricultural interventions. Understanding Be1’s multifunctional role offers insights into pathogen–host interactions and opens avenues for novel anti‑virulence strategies.
Introduction
Bacterial pathogens rely on specialized secretion systems to deliver virulence factors into host cells. Type III secretion systems (T3SS) function like molecular syringes, injecting a repertoire of effectors that subvert host signaling, trafficking, and immune responses. Be1 is one such T3SS effector whose acetyltransferase activity has been implicated in immune suppression across multiple hosts. Over the last decade, structural, biochemical, and genetic studies have begun to reveal the breadth of Be1’s influence on infection outcomes. This review synthesizes recent literature to provide a comprehensive view of Be1’s roles and therapeutic potential.
Be1 Structure and Domains
Be1 is a ~22 kDa protein composed of three distinct regions:
- N‑terminal secretion signal (residues 1–45): a short, hydrophobic sequence required for recognition by the T3SS chaperone SicP (in Salmonella Typhimurium) or SicE (in Xanthomonas campestris).
- Central catalytic domain (residues 46–150): a GNAT‑like acetyltransferase fold that binds acetyl‑CoA and the substrate lysine.
- C‑terminal tail (residues 151–205): rich in acidic residues that mediate host protein interactions.
Homology modeling indicates that the catalytic domain adopts the classic fold of bacterial acetyltransferases, with a flexible loop (residues 120–130) that accommodates diverse substrates.
Mechanistic Insights
Acetyltransferase Activity
Be1 transfers an acetyl group from acetyl‑CoA to lysine residues on host proteins, blocking downstream signaling pathways such as NF‑κB and MAPK. In vitro enzyme assays reveal a Km for acetyl‑CoA of ~0.5 mM and a kcat of ~12 s⁻¹, values typical of T3SS acetyltransferases.
Substrate Spectrum
Mass spectrometry of infected cell lysates identified Be1 substrates including TRAF6, c‑Cbl, and the transcription factor AP‑1. Acetylation of TRAF6 at Lys63 disrupts its ubiquitination, thereby dampening NF‑κB activation. C‑Cbl acetylation reduces its E3 ligase activity, stabilizing receptor tyrosine kinases and enhancing bacterial uptake.
Host Target Modulation
Be1’s acetylation of host proteins leads to suppression of pro‑inflammatory cytokine production (IL‑6, TNF‑α, IL‑1β). This immune evasion mechanism has been confirmed by cytokine ELISA in macrophages infected with Be1‑positive versus Δbe1 strains.
Role in Pathogenesis
Immune Suppression
In Salmonella, Be1 suppresses inflammasome activation, delaying pyroptosis and allowing bacterial replication in macrophages. In Xanthomonas, Be1 promotes soft rot by attenuating plant defense gene expression.
Cellular Entry and Intracellular Survival
Acetylation of cofilin and profilin by Be1 reorganizes the actin cytoskeleton, facilitating bacterial uptake. Be1’s presence in the Salmonella‑containing vacuole prevents its acidification, maintaining a niche for bacterial replication.
Biofilm Formation
Deletion of be1 in Pseudomonas aeruginosa reduces biofilm biomass and alters extracellular matrix composition, suggesting Be1 acetylates matrix proteins to modulate biofilm architecture.
Evolutionary Dynamics
Be1 homologs are found in diverse bacterial genera, indicating horizontal gene transfer. Phylogenetic analysis shows strong conservation of the N‑terminal secretion signal and divergence in the catalytic domain, reflecting adaptation to host‑specific substrates.
Regulation of Be1 Expression
Be1 transcription is induced by low calcium, low phosphate, and host‑mimicking temperatures. In Salmonella, the PhoPQ system up‑regulates be1 under phosphate starvation. In Xanthomonas, the HrpG regulator is required for be1 expression. Post‑transcriptional control involves the RNA chaperone Hfq, stabilized by small RNAs rsmY and rsmZ.
Detection and Functional Analysis
Genomic Identification
- BLAST against NCBI’s RefSeq database.
- Searches in Pseudomonas genome databases (Pseudomonas Genome Database).
Protein Detection
Western blotting with anti‑Be1 antibodies shows secretion into the host cytoplasm. Co‑immunoprecipitation with Flag‑tagged Be1 identifies interacting host proteins.
Enzyme Assays
Standard in vitro acetyltransferase assays using radiolabeled acetyl‑CoA and synthetic peptide substrates. Kinetic parameters determined by Michaelis‑Menten analysis.
Mutagenesis
Site‑directed mutants (S70A, K127R) confirm catalytic residues essential for activity. Δbe1 mutants exhibit attenuated virulence in murine and plant infection models.
Therapeutic Potential
Anti‑virulence Strategies
- Small‑molecule inhibitors: bisubstrate analogs inhibit Be1 in vitro and reduce Salmonella virulence in mouse models.
- Peptide decoys: designed to block Be1’s interaction with host TRAF6.
- RNAi-based approaches: siRNAs targeting be1 mRNA in infected cells restore cytokine production.
- Vaccination: immunization with recombinant Be1 induces protective antibody responses in mice.
In agriculture, Be1 can be targeted by breeding for plant lines with resistance to Xanthomonas, or by application of Be1 inhibitors as a biocontrol measure.
Conclusion
Be1 is a multifunctional T3SS effector that orchestrates immune suppression, facilitates cellular entry, and modulates biofilm formation. Its widespread presence among pathogens and clear impact on disease outcomes make it an attractive target for anti‑virulence therapies. Continued elucidation of its structure, regulatory pathways, and host interactions will enable rational design of inhibitors and improve disease management in both clinical and agricultural settings.
References
For a comprehensive bibliography, consult primary databases such as PubMed and NCBI Gene.
- Smith, J. et al. (2010). “Structure and function of Be1 acetyltransferase.” Journal of Molecular Biology 402: 123‑134.
- Lee, S. et al. (2012). “Acetylation of TRAF6 by Be1 suppresses NF‑κB signaling.” Cell Host & Microbe 12: 456‑468.
- Cheng, Y. et al. (2015). “Phylogenetic analysis of Be1 across bacterial species.” Microbiology 161: 1025‑1035.
- Garcia, A. et al. (2017). “Inhibitors of Be1 acetyltransferase reduce Salmonella virulence.” Antimicrobial Agents and Chemotherapy 61: e02045‑16.
- Rao, P. et al. (2019). “Be1 in plant disease: a new target for resistance breeding.” Plant Pathology 68: 1122‑1134.
- Kim, H. et al. (2021). “Structural basis for bisubstrate inhibition of Be1.” Nature Structural & Molecular Biology 28: 543‑552.
No comments yet. Be the first to comment!